Wire Stories
CANbridge Pharmaceuticals CAN108 New Drug Application (NDA) for Alagille Syndrome Accepted by China�s National Medical Products Administration
Priority Review Expected to be Granted BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc., (�CANbridge,� stock code 1228.HK) a leading China-based global biopharmaceutical...